Q5
LONG ANSWER
10M
★ High-yield
Classify adrenergic blocking drugs. Describe the pharmacological actions, uses and adverse effects of beta-blockers.
Classification of Adrenergic Blockers
| Group | Drugs | Features |
|---|---|---|
| Alpha — non-selective, irreversible | Phenoxybenzamine | Covalent, non-competitive; blockade lasts days |
| Alpha — non-selective, reversible | Phentolamine | Competitive and short-acting |
| Alpha1-selective | Prazosin, terazosin, doxazosin, tamsulosin | Less reflex tachycardia, because presynaptic alpha2 autoreceptors are left intact to restrain noradrenaline release |
| Alpha2-selective | Yohimbine | Little clinical use |
| Ergot alkaloids | Ergotamine, ergotoxine | Partial agonist and blocking actions |
| Beta — non-selective | Propranolol, timolol, nadolol, sotalol | Block beta1 and beta2 |
| Beta1-selective ("cardioselective") | Atenolol, metoprolol, bisoprolol, esmolol | Safer, though not safe, in asthma and diabetes; selectivity is lost at higher doses |
| With additional vasodilator action | Carvedilol and labetalol (also alpha1 block); nebivolol (releases nitric oxide) | Carvedilol is used in cardiac failure; labetalol in pregnancy and hypertensive emergency |
| With intrinsic sympathomimetic activity | Pindolol, acebutolol | Partial agonists; less bradycardia; avoided after myocardial infarction |
Beta-blockers — Actions and Uses
| Indication | Basis |
|---|---|
| Hypertension | Reduced cardiac output, reduced renin release, and a central effect; no longer first-line except in specific settings |
| Angina | Reduced heart rate, contractility and wall stress lower myocardial oxygen demand; the slower rate also lengthens diastole and improves coronary perfusion |
| After myocardial infarction | Proven reduction in mortality and reinfarction |
| Chronic cardiac failure | Carvedilol, bisoprolol, metoprolol succinate improve survival by opposing chronic sympathetic overactivity — started at a low dose and increased slowly, since abrupt full blockade worsens failure |
| Arrhythmia | Class II antiarrhythmic; rate control in atrial fibrillation |
| Thyrotoxicosis | Rapid symptomatic relief of tremor, palpitation and anxiety; propranolol also inhibits peripheral T4 to T3 conversion |
| Glaucoma | Timolol drops reduce aqueous humour formation |
| Others | Migraine prophylaxis, essential tremor, performance anxiety, portal hypertension (propranolol reduces variceal bleeding), phaeochromocytoma after alpha blockade |
CLINICAL PEARL
Beta-blockers are given in cardiac failure — the very condition they were once thought to cause. Acutely they reduce contractility and can decompensate a patient. But chronic sympathetic overactivity is itself what damages the failing heart, so blocking it improves survival over months. The resolution is entirely in the dosing: start very low, increase very slowly, and never in acute decompensation.
Adverse Effects and Contraindications
- Bronchospasm — beta2 blockade; asthma is a contraindication, and even cardioselective agents are used only with care
- Bradycardia and heart block; contraindicated in second and third degree block
- Worsening of acute cardiac failure and of peripheral vascular disease (cold extremities, claudication)
- Masking of hypoglycaemia in diabetics — tremor and palpitation are suppressed, though sweating is preserved because it is cholinergic; recovery from hypoglycaemia is also delayed
- Metabolic — raised triglycerides and reduced HDL; impaired glucose tolerance
- CNS — fatigue, nightmares, depression and reduced exercise tolerance, chiefly with lipid-soluble agents such as propranolol
- Abrupt withdrawal causes rebound angina, arrhythmia, hypertension and infarction, from receptor up-regulation; the dose must always be tapered
- Impotence, a frequent unstated reason for non-adherence
Alpha-blockers — Uses and Problems
- Phaeochromocytoma — phenoxybenzamine before surgery, with a beta-blocker added only afterwards; phentolamine for intra-operative crises
- Benign prostatic hyperplasia — tamsulosin, alfuzosin relax prostatic and bladder neck smooth muscle, giving rapid symptomatic relief
- Hypertension — prazosin and doxazosin; now used chiefly as add-on therapy
- First-dose phenomenon — marked postural hypotension and syncope after the first dose of prazosin; the first dose is small and given at bedtime
- Other effects — reflex tachycardia (much less with alpha1-selective agents), nasal stuffiness, failure of ejaculation, and intra-operative floppy iris syndrome with tamsulosin, which the ophthalmic surgeon must be told about before cataract surgery
Comparison of Alpha and Beta Blockade
| Feature | Alpha-blockers | Beta-blockers |
|---|---|---|
| Blood pressure | Falls by vasodilatation | Falls by reduced cardiac output and renin |
| Heart rate | Reflex tachycardia | Bradycardia |
| Postural hypotension | Marked | Uncommon |
| Effect on lipids | Favourable — HDL rises | Unfavourable |
| Bronchi | No effect | Bronchospasm |
| Chief uses | Phaeochromocytoma; prostatic hypertrophy | Angina, post-infarction, failure, arrhythmia, thyrotoxicosis |
Applied Aspects
- Never stop a beta-blocker abruptly — taper over one to two weeks; sudden withdrawal has precipitated fatal infarction
- Alpha before beta in phaeochromocytoma, without exception
- Give the first dose of prazosin at bedtime and warn the patient about standing up
- Beta-blocker overdose is treated with atropine, fluids, and glucagon, which raises cardiac cAMP by a route that bypasses the blocked beta receptor
- Ask about asthma before prescribing any beta-blocker, including timolol eye drops — topical ocular beta-blockers are absorbed systemically and have caused fatal bronchospasm
- Tell the ophthalmologist if a patient takes tamsulosin, because floppy iris syndrome complicates cataract surgery and forewarning changes the technique
- Beta-blockers are no longer first-line for uncomplicated hypertension in most guidelines, but remain first-line after infarction, in angina, in arrhythmia and in cardiac failure
- Esmolol has a half-life of minutes, which makes it useful where the effect may need to be withdrawn quickly — in perioperative and intensive care
- Labetalol is the beta-blocker of choice in pregnancy, and atenolol is avoided because of fetal growth restriction
- Timolol eye drops are absorbed systemically and have caused fatal bronchospasm and bradycardia; punctal occlusion after instillation reduces this
All questions in Autonomic Nervous System
- Q1Describe the organisation of the autonomic nervous system. Explain cholinergic and adrenergic transmission with receptor types and classify autonomic drugs. ★
- Q2Classify cholinergic drugs. Describe their pharmacological actions, uses and adverse effects. Add a note on organophosphorus poisoning. ★
- Q3Classify antimuscarinic drugs. Describe the pharmacological actions, therapeutic uses and toxicity of atropine. ★
- Q4Classify sympathomimetic drugs. Compare adrenaline, noradrenaline and isoprenaline and describe the uses of adrenaline. ★
- Q5Classify adrenergic blocking drugs. Describe the pharmacological actions, uses and adverse effects of beta-blockers. ★
- SN1Classify anticholinesterases. Differentiate neostigmine from physostigmine and describe their uses. ★
- SN2Classify skeletal muscle relaxants. Differentiate depolarising from non-depolarising blockers. ★
- SN3Classify antihypertensive drugs. Describe their adverse effects and the management of hypertensive emergency. ★
- SN4Classify the drugs used in glaucoma with their mechanisms and adverse effects. ★
- SN5Describe clonidine and methyldopa. Add a note on rebound hypertension. ★
- SN6Describe ganglion blocking drugs and explain their effects on the basis of dominant tone.
- SN7Describe the pharmacology of nicotine and the drugs used in smoking cessation. ★